[go: up one dir, main page]

AR053803A1 - Uso de acido pinolenico - Google Patents

Uso de acido pinolenico

Info

Publication number
AR053803A1
AR053803A1 ARP060100351A ARP060100351A AR053803A1 AR 053803 A1 AR053803 A1 AR 053803A1 AR P060100351 A ARP060100351 A AR P060100351A AR P060100351 A ARP060100351 A AR P060100351A AR 053803 A1 AR053803 A1 AR 053803A1
Authority
AR
Argentina
Prior art keywords
pinolenic acid
acid
pinolenic
food
derivative
Prior art date
Application number
ARP060100351A
Other languages
English (en)
Inventor
Jos Heimerikx
Ulrike
Stam Sandra Einerhand Wiro
Luisa Gambelli
Original Assignee
Loders Croklaan Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36756867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR053803(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Loders Croklaan Bv filed Critical Loders Croklaan Bv
Publication of AR053803A1 publication Critical patent/AR053803A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B39/00—Circuit arrangements or apparatus for operating incandescent light sources
    • H05B39/04—Controlling
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El ácido pinolénico o un derivado del mismo se pueden usar para el manejo del peso corporal. El ácido pinolénico, por ejemplo se puede usar bajo en la forma de un suplemento alimenticio, de una composicion farmacéutica o de una composicion alimenticia.
ARP060100351A 2005-01-31 2006-01-31 Uso de acido pinolenico AR053803A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05250517 2005-01-31
GBGB0514463.9A GB0514463D0 (en) 2005-01-31 2005-07-14 Use of pinolenic acid

Publications (1)

Publication Number Publication Date
AR053803A1 true AR053803A1 (es) 2007-05-23

Family

ID=36756867

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060100351A AR053803A1 (es) 2005-01-31 2006-01-31 Uso de acido pinolenico

Country Status (18)

Country Link
US (1) US20060172023A1 (es)
EP (2) EP1685834B1 (es)
JP (2) JP2006213711A (es)
KR (1) KR100895800B1 (es)
CN (1) CN1853621A (es)
AR (1) AR053803A1 (es)
AT (1) ATE429218T1 (es)
AU (1) AU2006200169B2 (es)
BR (1) BRPI0600199A (es)
CA (1) CA2533196C (es)
DE (1) DE602006006354D1 (es)
DK (1) DK1685834T3 (es)
ES (1) ES2344017T3 (es)
GB (1) GB0514463D0 (es)
MY (1) MY148723A (es)
PL (1) PL1685834T3 (es)
RU (1) RU2358476C2 (es)
ZA (1) ZA200600799B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2034983A1 (en) * 2006-06-27 2009-03-18 Lipid Nutrition B.V. Use of a polyunsaturated fatty acid compound
WO2008049198A1 (en) * 2006-10-27 2008-05-02 Iomedix Development International Srl Composition for weight loss comprising mulberry leaf, pinolenic acid and salacia oblonga extract
WO2008090198A1 (en) * 2007-01-25 2008-07-31 Janssen Pharmaceutica Nv Use of mtp inhibitors for increasing levels of satiety hormones
CN101686729A (zh) * 2007-04-24 2010-03-31 脂质营养品有限公司 饮料组合物
CA2684804A1 (en) * 2007-04-24 2008-10-30 Lipid Nutrition B.V. Yoghurt
WO2008154522A1 (en) * 2007-06-09 2008-12-18 Arizona Chemical Company Pinolenic acid compositions, products made thereof, and methods of making pinolenic acid compositions and products
EP2002730A1 (en) * 2007-06-11 2008-12-17 Lipid Nutrition B.V. Pinolenic acid compositions for treating fatty liver
EP2002731A1 (en) * 2007-06-11 2008-12-17 Lipid Nutrition B.V. Use of pinolenic acid for increasing lean body mass
EP2055198B1 (en) * 2007-10-29 2010-12-08 Lipid Nutrition B.V. Dressing composition
US20110052760A1 (en) * 2007-10-29 2011-03-03 Lipid Nutrition B.V. Soup or sauce composition and process for its production
EP2090172A1 (en) * 2007-10-29 2009-08-19 Lipid Nutrition B.V. Dough composition
KR101034458B1 (ko) * 2008-03-03 2011-05-17 고려대학교 산학협력단 피놀레닌산 고함유 δ5-지방산의 제조방법
WO2009118968A1 (ja) * 2008-03-26 2009-10-01 日清オイリオグループ株式会社 満腹感誘発剤及びこれを含有する飲食品
US20110098358A1 (en) * 2008-06-11 2011-04-28 Ricom Corporation Human beta3 adrenergic receptor ligand, and food or pharmaceutical product containing the same
JP6053695B2 (ja) * 2012-01-19 2016-12-27 日本水産株式会社 食欲抑制剤
US9456916B2 (en) 2013-03-12 2016-10-04 Medibotics Llc Device for selectively reducing absorption of unhealthy food
AU2014228387B2 (en) * 2013-03-11 2016-09-01 Sciadonics, Inc. Lipid compositions containing bioactive fatty acids
US9067070B2 (en) 2013-03-12 2015-06-30 Medibotics Llc Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type
JP2015205846A (ja) * 2014-04-22 2015-11-19 出光興産株式会社 レプチン分泌促進剤
CL2015003182A1 (es) * 2015-10-29 2016-04-29 Univ Concepcion Un producto nutracéutico modulador del apetito y sensibilizador a la insulina en mamíferos
US11058656B2 (en) * 2015-11-25 2021-07-13 Sciadonics, Inc. Lipid formulations containing bioactive fatty acids
KR101796034B1 (ko) * 2016-07-28 2017-11-09 강릉원주대학교 산학협력단 증포발효 인삼열매 추출물을 유효성분으로 함유하는 비만 치료용 조성물
WO2020028263A1 (en) * 2018-07-30 2020-02-06 Sciadonics, Inc. 5,11,14-eicosatrienoic acid compositions and methods for their production
AR114010A1 (es) * 2018-10-17 2020-07-08 Team Foods Colombia Sa Composición lipídica con micronutrientes para la prevención y/o el tratamiento de enfermedades metabólicas
KR102844667B1 (ko) * 2024-06-03 2025-08-11 주식회사 닥터스쿡 생리증후군 개선용 기능성 초콜렛 및 그 제조방법

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0070050B1 (en) * 1981-06-15 1984-09-19 Unilever N.V. Margarine fat blend
JPS6158536A (ja) 1984-08-31 1986-03-25 Nippon Oil & Fats Co Ltd 栄養組成物
JPS61238729A (ja) 1985-04-16 1986-10-24 Nippon Oil & Fats Co Ltd コレステロ−ル低下剤
US5567751A (en) * 1995-06-01 1996-10-22 Witco Corporation Alkyl-tin PVC stabilizers with added aromatic ether alcohol to prevent precipitation
FR2756465B1 (fr) 1996-12-03 1999-02-19 D A Noste Additif alimentaire, composition cosmetique et medicament a base d'huile de graines de pin
US5813416A (en) 1997-04-03 1998-09-29 Rudolph; James M. File with sanitizing agent
AU775774C (en) * 1999-04-15 2005-05-19 Kaneka Corporation Peroxisome proliferator-activated receptor agonist
US6838431B2 (en) 1999-07-27 2005-01-04 Pacific Health Laboratories, Inc. Nutritional intervention composition containing a source of proteinase inhibitor extending post meal satiety
DE60027376T2 (de) 1999-09-30 2007-02-01 Loders Croklaan B.V. Zusammensetzungen, enthaltend Pinolensäure sowie deren Verwendung zur Gesundheitserhaltung
DE60101859T2 (de) * 2000-02-24 2004-12-30 Unilever N.V. Pinolensäure gegen Diabetes
US7025984B1 (en) * 2000-06-26 2006-04-11 The Procter & Gamble Company Compositions and methods for body weight management
US6809115B2 (en) 2000-09-21 2004-10-26 Nutrition 21, Inc. Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols
JP4104814B2 (ja) * 2000-09-22 2008-06-18 株式会社カネカ 配合食用油脂
US6429190B1 (en) 2000-12-15 2002-08-06 Pacifichealth Laboratories, Inc. Method for extending the satiety of food by adding a nutritional composition designed to stimulate cholecystokinin(CCK)
DE10102050A1 (de) * 2001-01-17 2002-07-18 Basf Ag Zubereitung zur Verbesserung der Nahrungsverwertung
GB0105069D0 (en) * 2001-03-01 2001-04-18 Univ Ulster The Modified peptide
CN1164292C (zh) * 2001-04-05 2004-09-01 尹嘉斌 治疗高血脂及高血糖类疾病的天然药物
EP1390378B1 (en) * 2001-04-30 2009-06-17 Trommsdorff GmbH & Co. KG Arzneimittel Pharmaceutically active uridine esters
US20020192266A1 (en) * 2001-05-21 2002-12-19 Miles Douglas C. Therapeutic and nutritive dietary composition and method of use
US6888016B2 (en) * 2001-10-16 2005-05-03 Loders Croklaan Usa Llc Mixtures for stimulating glucose up-take
US20050038415A1 (en) * 2003-08-06 2005-02-17 Rohr William L. Method and apparatus for the treatment of obesity
ATE399474T1 (de) * 2004-03-06 2008-07-15 Cognis Ip Man Gmbh Use of unsaturated fatty acids for the reduction of appetite or food intake

Also Published As

Publication number Publication date
ZA200600799B (en) 2006-09-27
PL1685834T3 (pl) 2009-09-30
KR100895800B1 (ko) 2009-05-08
CA2533196A1 (en) 2006-07-31
CN1853621A (zh) 2006-11-01
AU2006200169B2 (en) 2007-08-23
RU2358476C2 (ru) 2009-06-20
KR20060093029A (ko) 2006-08-23
BRPI0600199A (pt) 2006-09-19
AU2006200169A1 (en) 2006-08-17
EP1685834B1 (en) 2009-04-22
EP1685834A1 (en) 2006-08-02
JP2012111778A (ja) 2012-06-14
JP2006213711A (ja) 2006-08-17
US20060172023A1 (en) 2006-08-03
CA2533196C (en) 2011-05-24
ES2344017T3 (es) 2010-08-16
DK1685834T3 (da) 2009-07-20
ATE429218T1 (de) 2009-05-15
GB0514463D0 (en) 2005-08-17
EP2072048A1 (en) 2009-06-24
DE602006006354D1 (de) 2009-06-04
RU2006102649A (ru) 2007-08-20
MY148723A (en) 2013-05-31

Similar Documents

Publication Publication Date Title
AR053803A1 (es) Uso de acido pinolenico
BRPI0816128A2 (pt) Uso de uma composição de estabilização, composição de estabilização, produto de cuidado corporal, e, produto doméstico.
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
EA201200550A1 (ru) Фармацевтические композиции, включающие bi-1356 и метформин
CR20110609A (es) Composicion antimicrobiana y metodos relacionados de uso
CO6440531A2 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
CR11232A (es) Compuestos de tiazolopirina modulares de sirtuina
GT201400111A (es) Triazolopiridinas sustituidas
DOP2012000150A (es) Triazolopiridinas
GT200800250A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
MX2012008717A (es) Composiciones para el cuidado oral.
UY30846A1 (es) Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
UY31484A1 (es) Piperidinas heteroaril-sustituidas
DOP2011000264A (es) Derivados de aminotetralina, composiciones farmaceuticas que los contienen y sus usos en terapia
CU20120171A7 (es) Triazolopiridinas sustituidas
CL2011000214A1 (es) Composicion farmaceutica que comprende progesterona micronizada y aceite de cartamo tipo ii; y uso para el tratamiento de una condicion relacionada con la insuficiencia de secrecion de progesterona.
CL2008002049A1 (es) Compuestos derivados de aminoindol macrociclicos; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c.
UY30163A1 (es) Nuevas ariltienopirimidinonas sustituidas con azaciclilo, procedimiento para su preparación y su uso como medicamentos
CL2007001752A1 (es) Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral.
ECSP11011224A (es) Derivados de tiadiazoles y oxadiazoles, su preparaciòn y su aplicaciòn en terapia
NI201000173A (es) Uso de dronedarona o una sal aceptable farmacéuticamente de ésta, para la preparación de un medicamento para regular el nivel de potasio en la sangre.
AR082215A1 (es) Composicion farmaceutica agradable al paladar
UY33040A (es) Nuevas formas polimorfas de {4,6diamino-2-[1-(2-fluorobencil-1h-pirazol[3,4-b]piridin-3-il]pirimidin-5-il}carbamato de metilo
UY32408A (es) Macrolido anti-inflamatorio

Legal Events

Date Code Title Description
FA Abandonment or withdrawal